Related Research Articles
Memorial Sloan Kettering Cancer Center is a cancer treatment and research institution in Manhattan in New York City. It was founded in 1884 as the New York Cancer Hospital. MSKCC is one of 72 National Cancer Institute-designated Comprehensive Cancer Centers. It had already been renamed and relocated, to its present site, when the Sloan-Kettering Institute for Cancer Research was founded in 1945, and built adjacent to the hospital. The two medical entities formally coordinated their operations in 1960, and formally merged as a single entity in 1980. Its main campus is located at 1275 York Avenue between 67th and 68th Streets in Manhattan.
Gynecologic oncology is a specialized field of medicine that focuses on cancers of the female reproductive system, including ovarian cancer, uterine cancer, vaginal cancer, cervical cancer, and vulvar cancer. As specialists, they have extensive training in the diagnosis and treatment of these cancers.
The Band of Parents is a 501(c)(3) nonprofit organization. Formed in July 2007 and incorporated in October 2007, it was founded by approximately 100 parents of young children with neuroblastoma who were treated at Memorial Sloan Kettering Cancer Center (MSKCC). Its purpose is to fund the development of new therapies for neuroblastoma that would not otherwise be pursued by research institutions or the pharmaceutical industry. The organization has become the largest single funder of neuroblastoma research at MSKCC.
Simon N. Powell is a British cancer researcher and radiation oncologist residing in New York City.
George Bosl is an American cancer researcher, holder of the Patrick M. Byrne Chair in Clinical Oncology at the Memorial Sloan-Kettering Cancer Center in New York City, and is a professor of medicine at the Weill Cornell Medical College. In 1997, he was appointed chair of the Department of Medicine at Sloan-Kettering, a position which he held until 2015. In 2019, he was named Memorial Sloan Kettering's first ombudsperson.
Peter B. Bach is a physician and writer in New York City. He is the Chief Medical Officer of DELFI Diagnostics and was previously an attending and researcher at Memorial Sloan-Kettering Cancer Center where he was the Director of the Center for Health Policy and Outcomes. His research focuses on healthcare policy, particularly as it relates to Medicare, racial disparities in cancer care quality, and lung cancer. Along with his scientific writings he is a frequent contributor to The New York Times and other newspapers.
The immune-related response criteria (irRC) is a set of published rules that define when tumors in cancer patients improve ("respond"), stay the same ("stabilize"), or worsen ("progress") during treatment, where the compound being evaluated is an immuno-oncology drug. Immuno-oncology, part of the broader field of cancer immunotherapy, involves agents which harness the body's own immune system to fight cancer. Traditionally, patient responses to new cancer treatments have been evaluated using two sets of criteria, the WHO criteria and the response evaluation criteria in solid tumors (RECIST). The immune-related response criteria, first published in 2009, arose out of observations that immuno-oncology drugs would fail in clinical trials that measured responses using the WHO or RECIST Criteria, because these criteria could not account for the time gap in many patients between initial treatment and the apparent action of the immune system to reduce the tumor burden.
Viviane Tabar is an American neurosurgeon, the Chair of the Department of Neurosurgery at Memorial Sloan Kettering Cancer Center in New York since 2017.
Nancy Y. Lee is a Taiwanese-born American physician and the vice-chair of the Department of Radiation Oncology in Memorial Sloan Kettering's Department of Medicine.
The University of Michigan Rogel Cancer Center is a cancer research and treatment institution based in Ann Arbor, Michigan, United States. The Rogel Cancer Center is affiliated with the University of Michigan and Michigan Medicine.
Tina Young Poussaint is a professor of radiology at the Harvard Medical School and a Neuroradiologist at the Boston Children's Hospital. In 2010 she served as President of the American Society of Pediatric Neuroradiology.
Carol L. Brown is the Nicholls-Biondi Chair for Health Equity at Memorial Sloan Kettering Cancer Center and a professor at Weill Cornell Medical College. She is a surgeon known for her work on gynecological cancers.
Kimmie Ng is a physician at Dana–Farber Cancer Institute who is known for her work on colorectal cancer in young patients.
Beth Ann Overmoyer is an American physician and oncologist. She is Director of the Inflammatory Breast Cancer Program at the Dana–Farber Cancer Institute.
Walter Lawrence Jr. was an American surgical oncologist at Memorial-Sloan-Kettering Cancer Center, Cornell Medical College, and at the Medical College of Virginia. He was a leader in civil rights health equity efforts.
Nancy Keating is an American physician who works at the Brigham and Women's Hospital and is a professor at Harvard Medical School. Her research considers the factors that influence quality care for people suffering from cancer.
Valerie W Rusch, MD, FACS, is an American thoracic surgeon who is currently the Miner Family Chair for Intrathoracic Cancers and Vice Chair for Clinical Research, Department of Surgery, at Memorial Sloan Kettering Cancer Center.
Patrick J. Loehrer is an American oncologist who is Indiana University Distinguished Professor, Joseph W. and Jackie J. Cusick Professor in Oncology, Professor of medicine, Indiana University School of Medicine; Director emeritus, Indiana University Melvin and Bren Simon Comprehensive Cancer Center.
Low anterior resection syndrome is a complication of lower anterior resection, a type of surgery performed to remove the rectum, typically for rectal cancer. It is characterized by changes to bowel function that affect quality of life, and includes symptoms such as fecal incontinence, incomplete defecation or the sensation of incomplete defecation, changes in stool frequency or consistency, unpredictable bowel function, and painful defecation (dyschezia). Treatment options include symptom management, such as use of enemas, or surgical management, such as creation of a colostomy.
The Immune Oncology Research Institute (IMMONC), established in April 2022 and headquartered in Yerevan, is a non-profit organization focusing on cancer research, treatment, and education. The institute's activities include conducting clinical research and building research capacity, with an emphasis on making cancer therapies accessible, particularly in low- and middle-income countries. IMMONC's role is to contribute to the global effort in cancer care through research and development in oncology.
References
- ↑ "WEDDINGS; Deborah Schrag, Yochai Benkler". The New York Times. 1992-08-23. ISSN 0362-4331 . Retrieved 2024-05-24.
- ↑ "Deb Schrag, MD, MPH, Named Chair of the Department of Medicine at Memorial Sloan Kettering Cancer Center". Memorial Sloan Kettering Cancer Center. October 4, 2021. Retrieved 2023-02-09.
- ↑ "Deb Schrag". Memorial Sloan Kettering Cancer Center. Retrieved 2023-02-09.
- ↑ Webster, Katherine (1997-05-15). "Early surgery may extend life for women with breast cancer gene". Fort Worth Star-Telegram. p. 10. Retrieved 2024-05-24.
- ↑ Tanner, Lindsey (2000-02-02). "Study cites pre-emptive breast surgery". The Times-Tribune. p. 7. Retrieved 2024-05-24.
- ↑ Kolata, Gina (2023-06-04). "Rectal Cancer Patients Could Be Spared the Effects of Radiation". The New York Times. ISSN 0362-4331 . Retrieved 2024-05-24.
- ↑ McLaughlin, Devin; Kunz, Pamela L (June 25, 2023). "Some patients with locally advanced rectal cancer can be spared pelvic radiation". HEM/ONC Today; Thorofare. Vol. 24, no. 9. p. 16 – via Proquest.
